Press Release

WASHINGTON (July 30, 2024) – The Council for Innovation Promotion (C4IP) celebrates the introduction of the Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act of 2024 in both the Senate and House today, and praises the original sponsors, Senators Chris Coons (D-DE) and Tom Cotton (R-AR), and Representatives Nathaniel Moran

WASHINGTON (April 29, 2024) — Today, Representatives Thomas Massie (R-KY) and Marcy Kaptur (D-OH) introduced the Restoring America’s Leadership in Innovation Act of 2024. Frank Cullen, executive director of the Council for Innovation Promotion, released the following statement applauding the legislation’s introduction: “C4IP thanks Representatives Massie and Kaptur for recognizing that we need to significantly

WASHINGTON (April 26, 2024) — Today, Executive Director of the Council for Innovation Promotion Frank Cullen released the following statement to mark this year’s World Intellectual Property Day, which focuses on how intellectual property (IP) contributes to and promotes sustainable development:

Today, the Council for Innovation Promotion (C4IP) released its inaugural Congressional Innovation Scorecard. The Scorecard assesses the record of every member of Congress on pivotal issues related to U.S. innovation and assigns a grade to each based on the extent to which they are working to advance strong and effective intellectual property rights that promote American innovation, creative output, and industry.

TYLER, TX (February 20, 2024) — Today, the Council for Innovation Promotion (C4IP) and the University of Texas at Tyler will host a roundtable event featuring special guest Congressman Nathaniel Moran, who represents Texas’ first district, along with local entrepreneurs, inventors, venture capitalists, and intellectual property experts. The roundtable will center on how East Texas

WASHINGTON, D.C. (February 12, 2024) — Today, the Council for Innovation Promotion (C4IP) opened applications for its summer internship program based in Washington, D.C. Interns will have an opportunity to work directly with nationally recognized IP experts, including two past directors of the U.S. Patent and Trademark Office and two former Judges of the United States Court of Appeals for the Federal Circuit.

WASHINGTON (February 2, 2024) — Today, former Commerce Secretaries Gary Locke and Carlos Gutierrez joined three former directors of U.S. Patent and Trademark Office and four former directors of the National Institute of Standards and Technology in urging the Biden administration to withdraw a draft NIST proposal that threatens trillions of dollars worth of future

WASHINGTON (December 26, 2023) — Today, President Biden allowed an import ban on certain Apple Watches to take effect. The ban was imposed by the United States International Trade Commission (USITC), which found that Apple had infringed two patents held by Masimo, an American medical device manufacturer. Frank Cullen, executive director of the Council for

WASHINGTON (December 8, 2023) — Today, C4IP Board Members and former Federal Circuit Court Judges Kathleen O’Malley and Paul Michel issued the following statement on the Biden administration’s decision to claim a newfound authority, under the 43-year-old Bayh-Dole Act, to rescind patent licenses on drugs, energy, climate change, and all other inventions that benefit from

WASHINGTON (December 7, 2023) — Today, the Biden administration claimed a newfound authority, under the 43-year-old Bayh-Dole Act, to rescind patent licenses on drugs, energy, climate change, and all other inventions that benefit from federal research funding. Frank Cullen, executive director of the Council for Innovation Promotion (C4IP), issued the following statement denouncing the decision:

WASHINGTON (December 5, 2023) — Yesterday, the Council for Innovation Promotion (C4IP) and nearly 50 former government officials and intellectual property experts sent a letter to President Biden urging his administration to oppose a proposal before the World Trade Organization to waive intellectual property rights for Covid-19 therapeutics and diagnostics. Notable letter signatories include former